<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>FDI Policy in Pharmaceutical Sector</title>
    <link>https://www.taxtmi.com/news?id=14174</link>
    <description>FDI policy permits investment in pharmaceuticals via the automatic route for greenfield projects and via government approval for brownfield projects; the automatic route also covers manufacturing of medical devices and equipment for both greenfield and brownfield investments. The policy prohibits non-compete clauses except in special circumstances subject to Foreign Investment Promotion Board approval, and allows the Government to impose conditions on brownfield approvals.</description>
    <language>en-us</language>
    <pubDate>Fri, 13 Mar 2015 15:19:30 +0530</pubDate>
    <lastBuildDate>Fri, 13 Mar 2015 15:19:30 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=378607" rel="self" type="application/rss+xml"/>
    <item>
      <title>FDI Policy in Pharmaceutical Sector</title>
      <link>https://www.taxtmi.com/news?id=14174</link>
      <description>FDI policy permits investment in pharmaceuticals via the automatic route for greenfield projects and via government approval for brownfield projects; the automatic route also covers manufacturing of medical devices and equipment for both greenfield and brownfield investments. The policy prohibits non-compete clauses except in special circumstances subject to Foreign Investment Promotion Board approval, and allows the Government to impose conditions on brownfield approvals.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Fri, 13 Mar 2015 15:19:30 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=14174</guid>
    </item>
  </channel>
</rss>